Data / Form D filings / Allay Therapeutics, Inc.
Allay Therapeutics, Inc.: Form D filings
Allay Therapeutics, Inc., a biotechnology company in San Jose, CA, filed 6 Form D notices with the SEC between 2019 and 2025. The latest, on February 10, 2025, reports $45 million sold of a $60 million offering to 18 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2720 ZANKER ROAD, San Jose, CA, 95134
- Phone
- (650) 514-6284
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1766366
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | New notice | $59,999,995 | $44,999,997 | $14,999,998 | 18 | Jan 24, 2025 | sec.gov |
| Dec 21, 2023 | Amendment | $86,890,346 | $86,890,346 | 22 | Sep 9, 2021 | sec.gov | |
| Sep 20, 2021 | New notice | $82,376,285 | $82,376,278 | $7 | 20 | Sep 9, 2021 | sec.gov |
| Jul 8, 2021 | Amendment | $18,000,000 | $15,000,000 | $3,000,000 | 7 | Apr 17, 2020 | sec.gov |
| May 1, 2020 | New notice | $15,000,000 | $12,000,000 | $3,000,000 | 7 | Apr 17, 2020 | sec.gov |
| Feb 12, 2019 | New notice | $28,752,807 | $15,752,807 | $13,000,000 | 14 | Jan 31, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Leighton A. Read | Director | |
| Mark A. Deem | Director | |
| Nicole A. Vitullo | Director | |
| Michael A. Carusi | Director | |
| Tiffany A. Le | Director | |
| Adam A. Gridley | Executive Officer, Director | |
| Paul A. McCreadie | Director | |
| J.C. A. Lopez | Director | |
| Anselm A. Tan | Director | |
| Kristen A. Howells | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 10, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Allay Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.